There are 2934 resources available
1433 - Comprehensive pan-cancer analysis of KRAS genomic alterations (GA) including potentially targetable subsets
Presenter: Sai-Hong Ou
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
4105 - Genetic variants in the one-carbon metabolism pathway to predict outcome in patients with metastatic colorectal cancer (mCRC): data from TRIBE and FIRE-3 phase III trials.
Presenter: Alberto Puccini
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
2381 - Oral Intestinal Alkaline Phosphatase Improves Efficacy of 5-FU in a Colorectal Cancer Mouse Model
Presenter: Christian Furlan Freguia
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
1699 - Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases
Presenter: Filippo Pietrantonio
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
3025 - Primary ovarian carcinomas arising in BRCA1 mutation carriers contain a small fraction of BRCA1-proficient cells, which rapidly repopulate tumor mass during neoadjuvant chemotherapy but become outgrown by BRCA1-deficient clones during platinum-free intervals
Presenter: Evgeny Imyanitov
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
4924 - Analysis of the Androgen Receptor status in liquid biopsy to predict the outcome to abiraterone and enzalutamide in CRPC patients
Presenter: Marzia Del Re
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
3707 - Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
Presenter: Francesca Battaglin
Session: Poster Discussion 2 – Translational research
Resources:
Abstract
Poster Discussion – NETs and endocrine tumours - Invited Discussant 1862PD, 1863PD, 1864PD and 1865PD
Presenter: Sophie Leboulleux
Session: Poster Discussion – NETs and endocrine tumours
Resources:
Slides
Webcast
Presentation by expert
Presenter: Vincent Launay-Vacher
Session: Drug interaction and the key role of kidney function in onco-haematology
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Miklos Pless
Session: How do we personalise treatment in stage III NSCLC?
Resources:
Slides
Webcast